nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0744	0.0952	CbGbCtD
Haloperidol—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0639	0.0818	CbGbCtD
Haloperidol—CYP1A1—Dexamethasone—ankylosing spondylitis	0.0619	0.0792	CbGbCtD
Haloperidol—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0495	0.0634	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0495	0.0634	CbGbCtD
Haloperidol—CYP2C19—Prednisone—ankylosing spondylitis	0.048	0.0614	CbGbCtD
Haloperidol—ABCB1—Betamethasone—ankylosing spondylitis	0.0415	0.0532	CbGbCtD
Haloperidol—ABCB1—Prednisolone—ankylosing spondylitis	0.041	0.0525	CbGbCtD
Haloperidol—ABCB1—Prednisone—ankylosing spondylitis	0.0387	0.0496	CbGbCtD
Haloperidol—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0383	0.049	CbGbCtD
Haloperidol—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0371	0.0475	CbGbCtD
Haloperidol—CYP2C19—Dexamethasone—ankylosing spondylitis	0.03	0.0383	CbGbCtD
Haloperidol—CYP3A4—Triamcinolone—ankylosing spondylitis	0.029	0.0371	CbGbCtD
Haloperidol—HTR1B—dura mater—ankylosing spondylitis	0.0259	0.424	CbGeAlD
Haloperidol—HTR1D—dura mater—ankylosing spondylitis	0.025	0.411	CbGeAlD
Haloperidol—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0249	0.0319	CbGbCtD
Haloperidol—CYP3A4—Betamethasone—ankylosing spondylitis	0.0249	0.0319	CbGbCtD
Haloperidol—CYP3A4—Prednisolone—ankylosing spondylitis	0.0246	0.0314	CbGbCtD
Haloperidol—ABCB1—Dexamethasone—ankylosing spondylitis	0.0242	0.0309	CbGbCtD
Haloperidol—CYP3A4—Prednisone—ankylosing spondylitis	0.0232	0.0297	CbGbCtD
Haloperidol—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0228	0.0291	CbGbCtD
Haloperidol—ABCB1—Methotrexate—ankylosing spondylitis	0.0194	0.0249	CbGbCtD
Haloperidol—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0145	0.0185	CbGbCtD
Haloperidol—HTR2A—vertebral column—ankylosing spondylitis	0.00374	0.0613	CbGeAlD
Haloperidol—CBR1—tendon—ankylosing spondylitis	0.00171	0.0281	CbGeAlD
Haloperidol—H1F0—tendon—ankylosing spondylitis	0.00141	0.023	CbGeAlD
Haloperidol—SIGMAR1—tendon—ankylosing spondylitis	0.00101	0.0166	CbGeAlD
Haloperidol—HTR2B—tendon—ankylosing spondylitis	0.00101	0.0166	CbGeAlD
Haloperidol—HRH1—tendon—ankylosing spondylitis	0.000647	0.0106	CbGeAlD
Haloperidol—Photosensitivity—Methotrexate—ankylosing spondylitis	0.000621	0.00393	CcSEcCtD
Haloperidol—Cardiac arrest—Prednisone—ankylosing spondylitis	0.00062	0.00393	CcSEcCtD
Haloperidol—Visual impairment—Prednisolone—ankylosing spondylitis	0.000598	0.00379	CcSEcCtD
Haloperidol—Weight increased—Dexamethasone—ankylosing spondylitis	0.000589	0.00373	CcSEcCtD
Haloperidol—Weight increased—Betamethasone—ankylosing spondylitis	0.000589	0.00373	CcSEcCtD
Haloperidol—Weight decreased—Betamethasone—ankylosing spondylitis	0.000586	0.00371	CcSEcCtD
Haloperidol—Weight decreased—Dexamethasone—ankylosing spondylitis	0.000586	0.00371	CcSEcCtD
Haloperidol—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.000584	0.0037	CcSEcCtD
Haloperidol—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.000584	0.0037	CcSEcCtD
Haloperidol—Dermatitis exfoliative—Methotrexate—ankylosing spondylitis	0.000578	0.00366	CcSEcCtD
Haloperidol—Visual disturbance—Methotrexate—ankylosing spondylitis	0.000575	0.00365	CcSEcCtD
Haloperidol—Hallucination—Methylprednisolone—ankylosing spondylitis	0.000567	0.00359	CcSEcCtD
Haloperidol—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00056	0.00355	CcSEcCtD
Haloperidol—Lethargy—Methotrexate—ankylosing spondylitis	0.000556	0.00352	CcSEcCtD
Haloperidol—Sweating increased—Prednisone—ankylosing spondylitis	0.000549	0.00348	CcSEcCtD
Haloperidol—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.000549	0.00348	CcSEcCtD
Haloperidol—HTR2A—tendon—ankylosing spondylitis	0.000541	0.00887	CbGeAlD
Haloperidol—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000532	0.00337	CcSEcCtD
Haloperidol—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000529	0.00335	CcSEcCtD
Haloperidol—Neutropenia—Prednisone—ankylosing spondylitis	0.000527	0.00334	CcSEcCtD
Haloperidol—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.000519	0.00329	CcSEcCtD
Haloperidol—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000517	0.00328	CcSEcCtD
Haloperidol—Hallucination—Betamethasone—ankylosing spondylitis	0.000515	0.00327	CcSEcCtD
Haloperidol—Hallucination—Dexamethasone—ankylosing spondylitis	0.000515	0.00327	CcSEcCtD
Haloperidol—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000515	0.00326	CcSEcCtD
Haloperidol—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000513	0.00325	CcSEcCtD
Haloperidol—Weight increased—Prednisone—ankylosing spondylitis	0.000513	0.00325	CcSEcCtD
Haloperidol—Weight decreased—Prednisone—ankylosing spondylitis	0.00051	0.00323	CcSEcCtD
Haloperidol—Vision blurred—Prednisolone—ankylosing spondylitis	0.000509	0.00323	CcSEcCtD
Haloperidol—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.000508	0.00322	CcSEcCtD
Haloperidol—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.000503	0.00319	CcSEcCtD
Haloperidol—Depression—Prednisone—ankylosing spondylitis	0.000501	0.00318	CcSEcCtD
Haloperidol—Visual impairment—Betamethasone—ankylosing spondylitis	0.000499	0.00316	CcSEcCtD
Haloperidol—Visual impairment—Dexamethasone—ankylosing spondylitis	0.000499	0.00316	CcSEcCtD
Haloperidol—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000499	0.00316	CcSEcCtD
Haloperidol—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000496	0.00314	CcSEcCtD
Haloperidol—Breast disorder—Methotrexate—ankylosing spondylitis	0.000493	0.00312	CcSEcCtD
Haloperidol—Vertigo—Prednisolone—ankylosing spondylitis	0.000486	0.00308	CcSEcCtD
Haloperidol—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000484	0.00307	CcSEcCtD
Haloperidol—Eye disorder—Betamethasone—ankylosing spondylitis	0.000484	0.00307	CcSEcCtD
Haloperidol—Angiopathy—Betamethasone—ankylosing spondylitis	0.00047	0.00298	CcSEcCtD
Haloperidol—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00047	0.00298	CcSEcCtD
Haloperidol—Convulsion—Prednisolone—ankylosing spondylitis	0.000468	0.00297	CcSEcCtD
Haloperidol—Hypertension—Prednisolone—ankylosing spondylitis	0.000467	0.00296	CcSEcCtD
Haloperidol—Alopecia—Dexamethasone—ankylosing spondylitis	0.000458	0.0029	CcSEcCtD
Haloperidol—Alopecia—Betamethasone—ankylosing spondylitis	0.000458	0.0029	CcSEcCtD
Haloperidol—Hallucination—Prednisone—ankylosing spondylitis	0.000449	0.00284	CcSEcCtD
Haloperidol—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000447	0.00284	CcSEcCtD
Haloperidol—Vertigo—Triamcinolone—ankylosing spondylitis	0.000447	0.00283	CcSEcCtD
Haloperidol—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000446	0.00282	CcSEcCtD
Haloperidol—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000443	0.00281	CcSEcCtD
Haloperidol—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000441	0.0028	CcSEcCtD
Haloperidol—Oedema—Prednisolone—ankylosing spondylitis	0.000441	0.0028	CcSEcCtD
Haloperidol—Neutropenia—Methotrexate—ankylosing spondylitis	0.000441	0.00279	CcSEcCtD
Haloperidol—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000434	0.00275	CcSEcCtD
Haloperidol—Convulsion—Triamcinolone—ankylosing spondylitis	0.000431	0.00273	CcSEcCtD
Haloperidol—Tachycardia—Prednisolone—ankylosing spondylitis	0.000431	0.00273	CcSEcCtD
Haloperidol—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.00043	0.00273	CcSEcCtD
Haloperidol—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00043	0.00272	CcSEcCtD
Haloperidol—Hypertension—Triamcinolone—ankylosing spondylitis	0.000429	0.00272	CcSEcCtD
Haloperidol—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000428	0.00271	CcSEcCtD
Haloperidol—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000426	0.0027	CcSEcCtD
Haloperidol—Eye disorder—Prednisone—ankylosing spondylitis	0.000422	0.00267	CcSEcCtD
Haloperidol—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000421	0.00267	CcSEcCtD
Haloperidol—Drowsiness—Methotrexate—ankylosing spondylitis	0.00042	0.00266	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000419	0.00266	CcSEcCtD
Haloperidol—Depression—Methotrexate—ankylosing spondylitis	0.000419	0.00265	CcSEcCtD
Haloperidol—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000414	0.00262	CcSEcCtD
Haloperidol—Angiopathy—Prednisone—ankylosing spondylitis	0.000409	0.00259	CcSEcCtD
Haloperidol—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000408	0.00259	CcSEcCtD
Haloperidol—Immune system disorder—Prednisone—ankylosing spondylitis	0.000408	0.00258	CcSEcCtD
Haloperidol—Oedema—Triamcinolone—ankylosing spondylitis	0.000406	0.00257	CcSEcCtD
Haloperidol—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000406	0.00257	CcSEcCtD
Haloperidol—Vertigo—Dexamethasone—ankylosing spondylitis	0.000405	0.00257	CcSEcCtD
Haloperidol—Vertigo—Betamethasone—ankylosing spondylitis	0.000405	0.00257	CcSEcCtD
Haloperidol—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000405	0.00257	CcSEcCtD
Haloperidol—Insomnia—Prednisolone—ankylosing spondylitis	0.000399	0.00253	CcSEcCtD
Haloperidol—Alopecia—Prednisone—ankylosing spondylitis	0.000399	0.00253	CcSEcCtD
Haloperidol—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000397	0.00252	CcSEcCtD
Haloperidol—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000397	0.00252	CcSEcCtD
Haloperidol—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000396	0.00251	CcSEcCtD
Haloperidol—Mental disorder—Prednisone—ankylosing spondylitis	0.000395	0.0025	CcSEcCtD
Haloperidol—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000395	0.0025	CcSEcCtD
Haloperidol—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000393	0.00249	CcSEcCtD
Haloperidol—Malnutrition—Prednisone—ankylosing spondylitis	0.000393	0.00249	CcSEcCtD
Haloperidol—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000392	0.00249	CcSEcCtD
Haloperidol—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000392	0.00248	CcSEcCtD
Haloperidol—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000391	0.00248	CcSEcCtD
Haloperidol—Convulsion—Dexamethasone—ankylosing spondylitis	0.000391	0.00248	CcSEcCtD
Haloperidol—Convulsion—Betamethasone—ankylosing spondylitis	0.000391	0.00248	CcSEcCtD
Haloperidol—Hypertension—Dexamethasone—ankylosing spondylitis	0.000389	0.00247	CcSEcCtD
Haloperidol—Hypertension—Betamethasone—ankylosing spondylitis	0.000389	0.00247	CcSEcCtD
Haloperidol—Anxiety—Dexamethasone—ankylosing spondylitis	0.000383	0.00242	CcSEcCtD
Haloperidol—Anxiety—Betamethasone—ankylosing spondylitis	0.000383	0.00242	CcSEcCtD
Haloperidol—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000378	0.0024	CcSEcCtD
Haloperidol—Hepatitis—Methotrexate—ankylosing spondylitis	0.000377	0.00239	CcSEcCtD
Haloperidol—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000372	0.00236	CcSEcCtD
Haloperidol—Vision blurred—Prednisone—ankylosing spondylitis	0.00037	0.00235	CcSEcCtD
Haloperidol—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00037	0.00234	CcSEcCtD
Haloperidol—Oedema—Betamethasone—ankylosing spondylitis	0.000368	0.00233	CcSEcCtD
Haloperidol—Oedema—Dexamethasone—ankylosing spondylitis	0.000368	0.00233	CcSEcCtD
Haloperidol—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000368	0.00233	CcSEcCtD
Haloperidol—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000368	0.00233	CcSEcCtD
Haloperidol—Insomnia—Triamcinolone—ankylosing spondylitis	0.000367	0.00233	CcSEcCtD
Haloperidol—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000366	0.00232	CcSEcCtD
Haloperidol—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000364	0.0023	CcSEcCtD
Haloperidol—Visual impairment—Methotrexate—ankylosing spondylitis	0.000363	0.0023	CcSEcCtD
Haloperidol—Anaemia—Prednisone—ankylosing spondylitis	0.000363	0.0023	CcSEcCtD
Haloperidol—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000362	0.00229	CcSEcCtD
Haloperidol—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000361	0.00229	CcSEcCtD
Haloperidol—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000361	0.00229	CcSEcCtD
Haloperidol—Agitation—Prednisone—ankylosing spondylitis	0.000361	0.00229	CcSEcCtD
Haloperidol—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00036	0.00228	CcSEcCtD
Haloperidol—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00036	0.00228	CcSEcCtD
Haloperidol—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000359	0.00228	CcSEcCtD
Haloperidol—Tachycardia—Betamethasone—ankylosing spondylitis	0.000359	0.00228	CcSEcCtD
Haloperidol—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000357	0.00226	CcSEcCtD
Haloperidol—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000356	0.00226	CcSEcCtD
Haloperidol—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000356	0.00225	CcSEcCtD
Haloperidol—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000356	0.00225	CcSEcCtD
Haloperidol—Vertigo—Prednisone—ankylosing spondylitis	0.000353	0.00224	CcSEcCtD
Haloperidol—Eye disorder—Methotrexate—ankylosing spondylitis	0.000352	0.00223	CcSEcCtD
Haloperidol—Anorexia—Dexamethasone—ankylosing spondylitis	0.000351	0.00222	CcSEcCtD
Haloperidol—Anorexia—Betamethasone—ankylosing spondylitis	0.000351	0.00222	CcSEcCtD
Haloperidol—Urticaria—Prednisolone—ankylosing spondylitis	0.00035	0.00222	CcSEcCtD
Haloperidol—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00035	0.00222	CcSEcCtD
Haloperidol—Hypotension—Betamethasone—ankylosing spondylitis	0.000344	0.00218	CcSEcCtD
Haloperidol—Hypotension—Dexamethasone—ankylosing spondylitis	0.000344	0.00218	CcSEcCtD
Haloperidol—Angiopathy—Methotrexate—ankylosing spondylitis	0.000342	0.00217	CcSEcCtD
Haloperidol—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000341	0.00216	CcSEcCtD
Haloperidol—Convulsion—Prednisone—ankylosing spondylitis	0.00034	0.00216	CcSEcCtD
Haloperidol—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00034	0.00215	CcSEcCtD
Haloperidol—Hypertension—Prednisone—ankylosing spondylitis	0.000339	0.00215	CcSEcCtD
Haloperidol—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000334	0.00212	CcSEcCtD
Haloperidol—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000334	0.00211	CcSEcCtD
Haloperidol—Anxiety—Prednisone—ankylosing spondylitis	0.000333	0.00211	CcSEcCtD
Haloperidol—Alopecia—Methotrexate—ankylosing spondylitis	0.000333	0.00211	CcSEcCtD
Haloperidol—Insomnia—Dexamethasone—ankylosing spondylitis	0.000333	0.00211	CcSEcCtD
Haloperidol—Insomnia—Betamethasone—ankylosing spondylitis	0.000333	0.00211	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000332	0.0021	CcSEcCtD
Haloperidol—Mental disorder—Methotrexate—ankylosing spondylitis	0.00033	0.00209	CcSEcCtD
Haloperidol—Malnutrition—Methotrexate—ankylosing spondylitis	0.000328	0.00208	CcSEcCtD
Haloperidol—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000325	0.00206	CcSEcCtD
Haloperidol—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000324	0.00205	CcSEcCtD
Haloperidol—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000324	0.00205	CcSEcCtD
Haloperidol—Urticaria—Triamcinolone—ankylosing spondylitis	0.000322	0.00204	CcSEcCtD
Haloperidol—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000322	0.00204	CcSEcCtD
Haloperidol—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000321	0.00203	CcSEcCtD
Haloperidol—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000321	0.00203	CcSEcCtD
Haloperidol—Oedema—Prednisone—ankylosing spondylitis	0.000321	0.00203	CcSEcCtD
Haloperidol—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00032	0.00203	CcSEcCtD
Haloperidol—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00032	0.00203	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000318	0.00201	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000318	0.00201	CcSEcCtD
Haloperidol—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000314	0.00199	CcSEcCtD
Haloperidol—Tachycardia—Prednisone—ankylosing spondylitis	0.000313	0.00198	CcSEcCtD
Haloperidol—Skin disorder—Prednisone—ankylosing spondylitis	0.000311	0.00197	CcSEcCtD
Haloperidol—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00031	0.00196	CcSEcCtD
Haloperidol—Vision blurred—Methotrexate—ankylosing spondylitis	0.000309	0.00196	CcSEcCtD
Haloperidol—Anorexia—Prednisone—ankylosing spondylitis	0.000306	0.00194	CcSEcCtD
Haloperidol—Anaemia—Methotrexate—ankylosing spondylitis	0.000303	0.00192	CcSEcCtD
Haloperidol—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000303	0.00192	CcSEcCtD
Haloperidol—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000303	0.00192	CcSEcCtD
Haloperidol—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000299	0.00189	CcSEcCtD
Haloperidol—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000298	0.00189	CcSEcCtD
Haloperidol—Vertigo—Methotrexate—ankylosing spondylitis	0.000295	0.00187	CcSEcCtD
Haloperidol—Leukopenia—Methotrexate—ankylosing spondylitis	0.000294	0.00186	CcSEcCtD
Haloperidol—Urticaria—Dexamethasone—ankylosing spondylitis	0.000292	0.00185	CcSEcCtD
Haloperidol—Urticaria—Betamethasone—ankylosing spondylitis	0.000292	0.00185	CcSEcCtD
Haloperidol—Dizziness—Prednisolone—ankylosing spondylitis	0.000292	0.00185	CcSEcCtD
Haloperidol—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000291	0.00184	CcSEcCtD
Haloperidol—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000291	0.00184	CcSEcCtD
Haloperidol—Insomnia—Prednisone—ankylosing spondylitis	0.00029	0.00184	CcSEcCtD
Haloperidol—Pruritus—Triamcinolone—ankylosing spondylitis	0.000287	0.00182	CcSEcCtD
Haloperidol—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000286	0.00181	CcSEcCtD
Haloperidol—Convulsion—Methotrexate—ankylosing spondylitis	0.000284	0.0018	CcSEcCtD
Haloperidol—Dyspepsia—Prednisone—ankylosing spondylitis	0.000282	0.00179	CcSEcCtD
Haloperidol—Decreased appetite—Prednisone—ankylosing spondylitis	0.000279	0.00177	CcSEcCtD
Haloperidol—Rash—Prednisolone—ankylosing spondylitis	0.000278	0.00176	CcSEcCtD
Haloperidol—Dermatitis—Prednisolone—ankylosing spondylitis	0.000278	0.00176	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000278	0.00176	CcSEcCtD
Haloperidol—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000277	0.00176	CcSEcCtD
Haloperidol—Headache—Prednisolone—ankylosing spondylitis	0.000276	0.00175	CcSEcCtD
Haloperidol—Constipation—Prednisone—ankylosing spondylitis	0.000274	0.00174	CcSEcCtD
Haloperidol—Confusional state—Methotrexate—ankylosing spondylitis	0.00027	0.00171	CcSEcCtD
Haloperidol—Dizziness—Triamcinolone—ankylosing spondylitis	0.000268	0.0017	CcSEcCtD
Haloperidol—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000268	0.0017	CcSEcCtD
Haloperidol—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000268	0.0017	CcSEcCtD
Haloperidol—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000264	0.00167	CcSEcCtD
Haloperidol—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000263	0.00166	CcSEcCtD
Haloperidol—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000262	0.00166	CcSEcCtD
Haloperidol—Nausea—Prednisolone—ankylosing spondylitis	0.000262	0.00166	CcSEcCtD
Haloperidol—Pruritus—Dexamethasone—ankylosing spondylitis	0.00026	0.00165	CcSEcCtD
Haloperidol—Pruritus—Betamethasone—ankylosing spondylitis	0.00026	0.00165	CcSEcCtD
Haloperidol—Skin disorder—Methotrexate—ankylosing spondylitis	0.00026	0.00165	CcSEcCtD
Haloperidol—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000259	0.00164	CcSEcCtD
Haloperidol—Vomiting—Triamcinolone—ankylosing spondylitis	0.000258	0.00163	CcSEcCtD
Haloperidol—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000257	0.00163	CcSEcCtD
Haloperidol—Rash—Triamcinolone—ankylosing spondylitis	0.000256	0.00162	CcSEcCtD
Haloperidol—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000256	0.00162	CcSEcCtD
Haloperidol—Anorexia—Methotrexate—ankylosing spondylitis	0.000255	0.00162	CcSEcCtD
Haloperidol—Rash—Methylprednisolone—ankylosing spondylitis	0.000255	0.00162	CcSEcCtD
Haloperidol—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000255	0.00162	CcSEcCtD
Haloperidol—Urticaria—Prednisone—ankylosing spondylitis	0.000255	0.00161	CcSEcCtD
Haloperidol—Headache—Triamcinolone—ankylosing spondylitis	0.000254	0.00161	CcSEcCtD
Haloperidol—Headache—Methylprednisolone—ankylosing spondylitis	0.000254	0.00161	CcSEcCtD
Haloperidol—Body temperature increased—Prednisone—ankylosing spondylitis	0.000253	0.00161	CcSEcCtD
Haloperidol—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000252	0.0016	CcSEcCtD
Haloperidol—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000252	0.0016	CcSEcCtD
Haloperidol—Hypotension—Methotrexate—ankylosing spondylitis	0.00025	0.00159	CcSEcCtD
Haloperidol—Dizziness—Dexamethasone—ankylosing spondylitis	0.000243	0.00154	CcSEcCtD
Haloperidol—Dizziness—Betamethasone—ankylosing spondylitis	0.000243	0.00154	CcSEcCtD
Haloperidol—Insomnia—Methotrexate—ankylosing spondylitis	0.000242	0.00154	CcSEcCtD
Haloperidol—Nausea—Triamcinolone—ankylosing spondylitis	0.000241	0.00153	CcSEcCtD
Haloperidol—Nausea—Methylprednisolone—ankylosing spondylitis	0.00024	0.00152	CcSEcCtD
Haloperidol—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000239	0.00151	CcSEcCtD
Haloperidol—Somnolence—Methotrexate—ankylosing spondylitis	0.000238	0.00151	CcSEcCtD
Haloperidol—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000236	0.0015	CcSEcCtD
Haloperidol—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000236	0.00149	CcSEcCtD
Haloperidol—Vomiting—Dexamethasone—ankylosing spondylitis	0.000234	0.00148	CcSEcCtD
Haloperidol—Vomiting—Betamethasone—ankylosing spondylitis	0.000234	0.00148	CcSEcCtD
Haloperidol—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000233	0.00148	CcSEcCtD
Haloperidol—Rash—Betamethasone—ankylosing spondylitis	0.000232	0.00147	CcSEcCtD
Haloperidol—Rash—Dexamethasone—ankylosing spondylitis	0.000232	0.00147	CcSEcCtD
Haloperidol—Dermatitis—Betamethasone—ankylosing spondylitis	0.000232	0.00147	CcSEcCtD
Haloperidol—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000232	0.00147	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000231	0.00147	CcSEcCtD
Haloperidol—Headache—Betamethasone—ankylosing spondylitis	0.000231	0.00146	CcSEcCtD
Haloperidol—Headache—Dexamethasone—ankylosing spondylitis	0.000231	0.00146	CcSEcCtD
Haloperidol—Pruritus—Prednisone—ankylosing spondylitis	0.000227	0.00144	CcSEcCtD
Haloperidol—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000221	0.0014	CcSEcCtD
Haloperidol—Diarrhoea—Prednisone—ankylosing spondylitis	0.000219	0.00139	CcSEcCtD
Haloperidol—Nausea—Betamethasone—ankylosing spondylitis	0.000219	0.00139	CcSEcCtD
Haloperidol—Nausea—Dexamethasone—ankylosing spondylitis	0.000219	0.00139	CcSEcCtD
Haloperidol—Urticaria—Methotrexate—ankylosing spondylitis	0.000213	0.00135	CcSEcCtD
Haloperidol—Dizziness—Prednisone—ankylosing spondylitis	0.000212	0.00134	CcSEcCtD
Haloperidol—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000212	0.00134	CcSEcCtD
Haloperidol—Vomiting—Prednisone—ankylosing spondylitis	0.000204	0.00129	CcSEcCtD
Haloperidol—Rash—Prednisone—ankylosing spondylitis	0.000202	0.00128	CcSEcCtD
Haloperidol—Dermatitis—Prednisone—ankylosing spondylitis	0.000202	0.00128	CcSEcCtD
Haloperidol—Headache—Prednisone—ankylosing spondylitis	0.000201	0.00127	CcSEcCtD
Haloperidol—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000197	0.00125	CcSEcCtD
Haloperidol—Nausea—Prednisone—ankylosing spondylitis	0.00019	0.00121	CcSEcCtD
Haloperidol—Pruritus—Methotrexate—ankylosing spondylitis	0.00019	0.0012	CcSEcCtD
Haloperidol—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000183	0.00116	CcSEcCtD
Haloperidol—Dizziness—Methotrexate—ankylosing spondylitis	0.000177	0.00112	CcSEcCtD
Haloperidol—Vomiting—Methotrexate—ankylosing spondylitis	0.00017	0.00108	CcSEcCtD
Haloperidol—Rash—Methotrexate—ankylosing spondylitis	0.000169	0.00107	CcSEcCtD
Haloperidol—Dermatitis—Methotrexate—ankylosing spondylitis	0.000169	0.00107	CcSEcCtD
Haloperidol—Headache—Methotrexate—ankylosing spondylitis	0.000168	0.00106	CcSEcCtD
Haloperidol—Nausea—Methotrexate—ankylosing spondylitis	0.000159	0.00101	CcSEcCtD
